12
Participants
Start Date
August 1, 2019
Primary Completion Date
June 30, 2024
Study Completion Date
June 30, 2028
Regulatory T cells
Single infusion of expanded regulatory T cells.
Tocilizumab
Treatment during first month post-transplant.
Bone marrow
Infusion of donor bone marrow cells.
Kidney transplant
Living donor kidney transplantation.
Immunosuppressive drug therapy
Immunosuppressive drug therapy.
Medical University of Vienna/Vienna General Hospital, Vienna
University Hospital Regensburg
OTHER
Thomas Wekerle
OTHER